SEC Form 4 · accession 0001144204-17-036573
Checkpoint Therapeutics, Inc. · CKPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lindsay A Rosenwald M.D.
Director
Period of report
Jul 10, 2017
Accepted (ET)
Jul 12, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jul 10, 2017 | A | 10,000 | $0.00 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The 10,000 shares of restricted Common Stock will vest on July 10, 2020, subject to Dr. Rosenwald's continued service on the board on such date.